Your Cart Item
Reports Within

Parameters

Reports Within:

Parameter Include:

Requisites
Measures

Number of red blood cells in the blood

Identifies

Red blood cell disorders

Measures: Number of red blood cells in the blood

Identifies: Red blood cell disorders

60
Mins

Homes

1M
Happy

Customers

4.9
Google

Rating

Certified

Labs

What is the maximum days the report can be obtained for the test

The maximum days the report can be obtained for the 14q32.3 Gene Rearrangement (ALL, NHL) Test By FISH is typically within 10-14 business days from the receipt of the sample at the testing laboratory.

What are the prerequisites for the test 14q32.3 Gene Rearrangement (ALL, NHL) Test By FISH

  • Specimen Type: Bone marrow aspirate or peripheral blood
  • Container/Tube: Lavender top (EDTA) tube
  • Specimen Volume: 5 mL
  • Collection Instructions: Mix well
  • Storage Instructions: Maintain specimen at room temperature
  • Stability: Unstable at room temperature; stable for 48 hours at 2-8°C
  • Rejection Criteria: Clotted or hemolyzed specimens

What are the measure values for the test 14q32.3 Gene Rearrangement (ALL, NHL) Test By FISH

  • Normal: 1 signal
  • Abnormal: Extra signals, or one fused signal

What does this test 14q32.3 Gene Rearrangement (ALL, NHL) Test By FISH identify?

  • Test Name: 14q32.3 Gene Rearrangement (ALL, NHL) Test By FISH
  • Identifies: This test is used to identify genetic rearrangements involving the 14q32.3 region in patients with Acute Lymphoblastic Leukemia (ALL) or Non-Hodgkin Lymphoma (NHL).
  • Method: Fluorescence In Situ Hybridization (FISH) technique is used to detect specific genetic abnormalities in the 14q32.3 region.
  • Significance: Rearrangements in the 14q32.3 region can help in the diagnosis, prognosis, and treatment selection for patients with ALL or NHL.

Why is this test 14q32.3 Gene Rearrangement (ALL, NHL) Test By FISH taken?

  • This test is taken to detect rearrangements involving the 14q32.3 gene in patients with Acute Lymphoblastic Leukemia (ALL) or Non-Hodgkin Lymphoma (NHL).
  • It helps in identifying specific genetic changes that may be associated with these types of cancers.
  • The test is important for determining the prognosis and treatment options for patients with ALL or NHL.
  • By analyzing the 14q32.3 gene rearrangement using Fluorescence In Situ Hybridization (FISH) technique, healthcare providers can better understand the genetic profile of the cancer and tailor treatment accordingly.

No FAQs available.

Customer Google Rating